A single-center, double-blind, randomized, placebo-controlled clinical study of Shuhe granule in the treatment of chronic insomnia with qi-blood disharmony and deficiency of both heart and kidney

INTERVENTION: Control group:placebo; CONDITION: insomnia PRIMARY OUTCOME: The total socres of Insomnia Severity Index (ISI); SECONDARY OUTCOME: Syndrome score of traditional Chinese medicine;Generalized anxiety Disorder scale (GAD‐7);Visual analogue fatigue score (VFAS);The total scores and the various scores of the Pittsburgh sleep quality index;Syndrome score of traditional Chinese medicine;Patient Health Questionnaire(PHQ‐9);Fatigue severity scale (FSS); INCLUSION CRITERIA: (1) 18 to 65 years of age. (2) meet the diagnostic criteria of chronic insomnia in western medicine. (3) meet the diagnostic criteria of insomnia in traditional Chinese medicine. (4) consistent with the syndrome of disharmony between qi and blood and deficiency of both heart and kidney. (5) sign the informed consent form.